Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer

International Journal of Clinical Oncology

Volumn 15, Issue 3, 2010, Pages 294-300

  Imai, Hisashi ^a   Doi, Ryuichiro ^a   Kanazawa, Hiroyuki ^a   Kamo, Naoko ^a   Koizumi, Masayuki ^a   Masui, Toshihiko ^a   Iwanaga, Yasuhiro ^a   Kawaguchi, Yoshiya ^a   Takada, Yasutsugu ^a   Isoda, Hiroyoshi ^a   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Diagnostic imaging; Invasive ductal carcinoma of the pancreas; Para aortic lymph node metastasis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER SIZE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PARAAORTIC LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; CANCER STAGING; CARCINOMA, PANCREATIC DUCTAL; CHI SQUARE DISTRIBUTION; DIAGNOSTIC USE; JAPAN; LYMPH NODE; LYMPH NODE DISSECTION; MIDDLE AGED; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; PREDICTIVE VALUE; PREOPERATIVE CARE; RADIOGRAPHY; SCINTISCANNING; SECONDARY; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CHI-SQUARE DISTRIBUTION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; JAPAN; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955714576     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-010-0066-5     Document Type: Article

References (33)

1. Matsuno S, Egawa S, Fukuyama S et al (2004) Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas 28:219-230
2. Herrmann R, Jelic S (2008) Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19(Suppl 2):ii25-ii26
3. Riall TS, Cameron JL, Lillemoe KD et al (2005) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma- part 3: update on 5-year survival. J Gastrointest Surg 9:1191-1204 (discussion 204-206)
4. Doi R, Kami K, Ito D et al (2007) Prognostic implication of paraaortic lymph node metastasis in resectable pancreatic cancer. World J Surg 31:147-154
5. Kayahara M, Nagakawa T, Ohta T et al (1999) Analysis of paraaortic lymph node involvement in pancreatic carcinoma: a significant indication for surgery? Cancer 85:583-590
6. Schwarz M, Pauls S, Sokiranski R et al (2001) Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective? Am J Surg 182:243-249
7. Soriano A, Castells A, Ayuso C et al (2004) Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 99:492-501
8. Parsons CM, Sutcliffe JL, Bold RJ (2008) Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 15:429-435
9. Japan Pancreas Society (2003) Classification of pancreatic carcinoma, 2nd English edn. Kanehara & Co., Tokyo
10. Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York
11. Committee on Classification of Regional Lymph Nodes of Japan Society of Clinical Oncology (2003) Classification of regional lymph nodes in Japan. Int J Clin Oncol 8:248-275
12. Yoshida T, Matsumoto T, Sasaki A et al (2004) Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma. Am J Surg 187:736-740
13. Shimada K, Sakamoto Y, Sano T et al (2006) The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. J Am Coll Surg 203:345-352
14. de Bondt RB, Nelemans PJ, Hofman PA et al (2007) Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 64:266-272
15. Hovels AM, Heesakkers RA, Adang EM et al (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63:387-395
16. Karmazanovsky G, Fedorov V, Kubyshkin V et al (2005) Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging 30:488-500
17. Roche CJ, Hughes ML, Garvey CJ et al (2003) CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. Am J Roentgenol 180:475-480
18. Seo S, Doi R, Machimoto T et al (2008) Contribution of 18F-fluorodeoxyglucose positron-emission tomography to the diagnosis of early pancreatic carcinoma. J Hepatobiliary Pancreat Surg 15:634-639
19. Rose DM, Delbeke D, Beauchamp RD et al (1999) 18Fluorodeoxyglucose- positron-emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 229:729-737 (discussion 37-38)
20. Berberat P, Friess H, Kashiwagi M et al (1999) Diagnosis and staging of pancreatic cancer by positron-emission tomography. World J Surg 23:882-887
21. Sperti C, Pasquali C, Chierichetti F et al (2001) Value of 18-fluorodeoxyglucose positron-emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg 234:675-680
22. Imdahl A, Nitzsche E, Krautmann F et al (1999) Evaluation of positron-emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg 86:194-199
23. Golder WA (2004) Lymph node diagnosis in oncologic imaging: a dilemma still waiting to be solved. Onkologie 27:194-199
24. Wunderbaldinger P (2006) Problems and prospects of modern lymph node imaging. Eur J Radiol 58:325-337
25. Bares R, Dohmen BM, Cremerius U et al (1996) Results of positron-emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma. Radiologe 36:435-440
26. Bares R, Klever P, Hauptmann S et al (1994) F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 192:79-86
27. Diederichs CG, Staib L, Vogel J et al (2000) Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20:109-116
28. Pakzad F, Groves AM, Ell PJ (2006) The role of positron-emission tomography in the management of pancreatic cancer. Semin Nucl Med 36:248-256
29. Kim JK, Kim KA, Park BW et al (2008) Feasibility of diffusionweighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging 28:714-719
30. Holzapfel K, Duetsch S, Fauser C et al (2008) Value of diffusionweighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2008 (online first)
31. Saokar A, Braschi M, Harisinghani M (2006) Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging. Abdom Imaging 31:660-667 (Pubitemid 46723637)
32. Heesakkers RA, Hovels AM, Jager GJ et al (2008) MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 9:850-856
33. Veit P, Ruehm S, Kuehl H et al (2006) Lymph node staging with dual-modality PET/CT: enhancing the diagnostic accuracy in oncology. Eur J Radiol 58:383-389